人EGFL7基因RNA干扰慢病毒载体的构建及其在人喉癌细胞中的表达

 目的：构建人表皮生长因子样结构域7（epidermal growth factor-like domain 7, EGFL7）基因RNA干扰（RNA interference, RNAi）慢病毒表达载体，并建立稳定干扰EGFL7基因表达的喉癌细胞亚系，为研究EGFL7蛋白在喉癌发生发展中的功能奠定基础。方法：针对人EGFL7基因序列，设计特异性RNAi靶序列，与pcDNA6.2-GW/EmGFP-miR线性载体定向连接，得到的阳性重组子再与pLenti6.3-MCS/V5-DEST慢病毒载体进行重组，获得真核表达慢病毒干扰载体。在POLOdelivererTM 3000介导下将慢病毒包装质粒和EGFL7基因重组慢病毒载体导入293T细胞包装病毒，测定病毒滴度，感染人喉癌细胞HEp-2，杀稻瘟菌素筛选获得稳定干扰EGFL7基因的细胞亚系。结果：成功构建EGFL7 pLenti6.3-EGFL7-miR真核表达慢病毒干扰载体并获得相应慢病毒，经测定病毒滴度为5×1011 TU/L，实时荧光定量PCR证实pLenti6.3-EGFL7-miR慢病毒载体对喉癌细胞HEp-2 EGFL7基因的沉默效率为97%。结论：成功构建人EGFL7基因特异性的慢病毒干扰载体，并获得EGFL7基因稳定干扰的喉癌细胞亚系。

Construction of a lentiviral vector for RNA interference of human EGFL7 gene and its stable expression in human laryngeal carcinoma cells

AIM：To investigate the role of epidermal growth factor-like domain 7 (EGFL7) in the pathogenesis and progress of laryngeal carcinoma via constructing a lentiviral expression vector for RNA interference (RNAi) of human EGFL7 gene and assessing the gene-silencing effect of the vector in human laryngeal epidermoid carcinoma (HEp-2) cells. METHODS：Specific RNAi target sequences were designed focused on human EGFL7 gene sequence. The double-stranded oligonucleotides were cloned into the pcDNA6.2-GW/EmGFP-miR plasmid after synthesis and annealing. A positive clone was subcloned into the pLenti6.3-MCS/V5-DEST vector after sequence analysis. The recombinant lentivirus was harvested from 293T cells co-transfected with the positive recombinant plasmid and lentiviral packing materials. HEp-2 cells were infected with the recombinant lentivirus and the cells with stable EGFL7 knockdown were screened by blasticidin selection.  EGFL7 mRNA expression in the cells was determined by real-time fluorescence quantitative PCR. RESULTS：A recombinant lentiviral vector expressing short hairpin RNAs (shRNAs) against EGFL7 gene was obtained and confirmed by DNA sequencing. The virus titer was 5×1011 TU/L, and the silencing efficiency was 97%. CONCLUSION：A lentiviral vector targeting human EGFL7 gene, capable of stable EGFL7 gene knockdown in HEp-2 cells, has been successfully constructed, which provides a basis for further study of the relationship between human laryngeal carcinoma and EGFL7 protein.